ロード中...
Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
The results of our third trial on epicutaneous allergen-specific immunotherapy (EPIT) will be presented and discussed in the context of our previous trials. This monocentric, placebo-controlled, double-blind phase I/IIa trial included 98 patients with grass pollen rhinoconjunctivitis. Prior to the p...
保存先:
| 出版年: | Allergy |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4654258/ https://ncbi.nlm.nih.gov/pubmed/25704072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/all.12600 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|